| Item | Amount | Y/Y |
|---|---|---|
| Revenue | $5.41B | +5.8% |
| Gross profit | $5.41B | — |
| Operating income | $0.84B | — |
| Net income | $0.66B | -0.2% |
| Gross margin | 100.0% | Net margin 12.2% |
| Segment | Revenue | Share |
|---|---|---|
| Financial Services | $1.19B | 21.9% |
| Health Sciences | $0.91B | 16.9% |
| Productsand Resources | $0.90B | 16.6% |
| Health Sciences | $0.67B | 12.3% |
| Communications Media And Technology | $0.49B | 9.1% |
| Financial Services | $0.46B | 8.5% |
| Productsand Resources | $0.42B | 7.8% |
| Communications Media And Technology | $0.38B | 7.0% |
| Item | Amount | % of revenue |
|---|---|---|
| SG&A | $0.79B | 14.6% |
| Tax & other | $0.18B | 3.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
COHR ・ COIN ・ CL ・ CMCSA ・ FIX ・ COP ・ ED ・ STZ ・ CEG ・ COO ・ CPRT ・ GLW
Source: SEC EDGAR · This page shows public filing data only, not investment advice. · Browse all companies